Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure-Reference-Cited by-同舟云学术

Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure

Published:2011-04 Issue:1 Volume:407 Page:219-224
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Azuma Koichi,Tsurutani Junji,Sakai Kazuko,Kaneda Hiroyasu,Fujisaka Yasuhito,Takeda Masayuki,Watatani Masahiro,Arao Tokuzo,Satoh Taroh,Okamoto Isamu,Kurata Takayasu,Nishio Kazuto,Nakagawa Kazuhiko

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference14 articles.

1. Estimates of worldwide burden of cancer in 2008, GLOBOCAN 2008;Ferlay;Int. Cancer.,2010

2. Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene;Slamon;Science,1987

3. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients;DiGiovanna;J. Clin. Oncol.,2005

4. Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells;Konecny;Cancer Res.,2006

5. Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer;Scaltriti;J. Natl. Cancer Inst.,2007

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapeutic Activity of Imidazolium-Supported Pd(II) o-Vanillylidene Diaminocyclohexane Complexes Immobilized in Nanolipid as Inhibitors for HER2/neu and FGFR2/FGF2 Axis Overexpression in Breast Cancer Cells;Pharmaceuticals;2023-12-11

2. AXL – a new player in resistance to HER2 blockade;Cancer Treatment Reviews;2023-12

3. Transglutaminase-2 mediates acquisition of neratinib resistance in metastatic breast cancer;Molecular Biomedicine;2022-06-22

4. Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study;International Journal of Colorectal Disease;2022-05-19

5. Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer;Open Biology;2022-02